But then Roche/Genentech will know imu, thanks to Leslie. There's already a sponsored trial planned.
Merck have had dealings with Paul Hooper, and they perhaps stand to lose the most if B cells take over T cell therapies, along with Bristol Myers.
To be honest print a list of the world's biggest pharma companies and that's the potential partners list.
imu's pipeline has such an enormous potential that anybody could be interested, and personally I think that interest will come sooner rather than later.
Somebody mentioned the other day that nothing is likely to happen for 12 months, but I think a deal/takeover could come at anytime.
Large potential game changing early stage biotech deals are commonplace, and imu have an enormously large potential imho.
Cheers
Add to My Watchlist
What is My Watchlist?
